T.J. Dillashaw has revealed that the New York State Athletic Commission (NYSAC) and USADA have informed him of an “adverse finding” from a drug test stemming from his first-round loss to Henry Cejudo, who he faced for the flyweight title at UFC Brooklyn in January.
Dillashaw also revealed that he would relinquish his UFC bantamweight title out of “fairness and respect” for the rest of the division until the matter is resolved.
The former bantamweight champion broke the news of the findings and his relinquishing of the title on social media on Wednesday morning.
The post read:
“To all my fans, I wanted to be the first one to let you know that USADA and the NYSAC have informed me of an adverse finding in a test taken from my last fight. While words can’t even begin to express how disappointed I am at this time, please know that I’m working with my team to understand what has occurred and how to resolve this situation as quickly as possible. Out of fairness and respect to the rest of the my division, I’ve informed the UFC that I’ll be voluntarily relinquishing my title while I deal with this matter. I want to thank all of you in advance.”
Dillashaw has also been suspended for a year by NYSAC. It released the following statement.
The New York State Athletic Commission issued a one-year suspension and $10 thousand fine to Mr. Dillashaw for violations relating to use of a prohibited substance. We have no further comment.
USADA released the following statement about the situation.
“In light of Mr. Dillashaw’s social media post this morning, we can confirm that an in-competition test conducted by USADA on January 18, 2019 resulted in an adverse analytical finding. In this instance, we are able to confirm the finding due to Mr. Dillashaw’s public statement. The presumption of innocence under the rules is a vital part of an effective anti-doping program and it’s only fair that Mr. Dillashaw be allowed due process before any conclusions are drawn.”